Amgen Inc. Other Restructuring Costs
Amgen Inc. (AMGN) reported Other Restructuring Costs of $76.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2018-02-13
- Amgen Inc. other restructuring costs for the quarter ending 2015-12-31 was $11.00M.
- Amgen Inc. other restructuring costs for the quarter ending 2015-09-30 was $18.00M, a 157.14% increase year-over-year.
- Amgen Inc. other restructuring costs for the quarter ending 2015-06-30 was $31.00M.
- Amgen Inc. other restructuring costs for the quarter ending 2015-03-31 was $16.00M.
- Amgen Inc. other restructuring costs for fiscal 2015 was $76.00M, a 94.87% increase from fiscal 2014.
- Amgen Inc. other restructuring costs for fiscal 2014 was $39.00M.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month |
|---|---|---|---|---|
| 2015-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $29.00M derived: sum of 2 quarters · filed 2018-02-13 | $60.00M derived: sum of 3 quarters · filed 2018-02-13 | $76.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $18.00M 10-Q · filed 2015-11-02 | $49.00M derived: sum of 2 quarters · filed 2015-11-02 | $65.00M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $31.00M 10-Q · filed 2015-08-05 | $47.00M 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | $16.00M 10-Q · filed 2015-04-27 | |||
| 2014-12-31 | $39.00M 10-K · filed 2018-02-13 | |||
| 2014-09-30 | $7.00M 10-Q · filed 2014-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |